Research Topic

Signal Transduction and Cancer

About this Research Topic

Cancer Development is a multistep process, involving cellular mutation, with selectivity for cells with a high proliferative capacity, survival, invasion and metastasis. The signal transduction pathways that regulate normal cell growth are usually disrupted and abnormal in cancer cells. The mechanisms of these dysregulated signaling pathways provide unique characteristic properties and descriptions of the malignancy at the molecular and cellular level. The loss of growth control observed in the cancer cells is the result of the accumulation of multiple, disordered steps in the regulated signaling cascade. Understanding the regulatory mechanisms and the specific connections in the various signal transduction pathways during cancer progression will help researchers to design futuristic and targeted therapies. Additionally, complex interconnections between signaling pathways may hold the key for a long term cancer cure.

The aim of this Research Topic is to further the understanding of basic cancer biology with regards to signaling pathways and an associated focus on therapeutics and clinical discoveries. Efforts should also be focused on developing understanding around the mechanism of action of therapeutic drugs. Tamoxifen and platinum, for example, are used extensively in treating certain types of tumors but are still poorly understood in terms of the signaling pathways which they target. Equally, the tumor microenvironment, metabolic content and signaling pathways could hold solutions to explaining the positive and negative responses to cancer therapies. Additional investigation into multi-dimensional strategies encompassing signaling molecules, RNAi, antibodies and small molecule inhibitors could provide the necessary specificity to distinguish cancer cells from their normal counterparts, which could provide an opportunity to explore future therapies which correct these distorted pathways.

In our Research Topic, articles that focus on but are not limited to the following topics are welcomed:

- The process by which normal cells are transformed into malignant cells through the changes in the microenvironment.
- Processes that modify the cellular activities and gene expression of an amplified cellular response, with priming of receptor ligand activity and cascading events of the intracellular biochemical pathways.
- Activation of kinases which alter post-translational modifications of key proteins, and investigation of the functional implications of such changes.
- The role of non-enzymatic secondary messengers, including lipids, adaptor proteins and ion binding proteins.
- Signaling pathways downstream of RTKs targeted by the PI3K-Akt pathway, the Ras GTPase, Raf-MEK-ERK MAP kinase, GAP-Rheb GTPase , Wnt signaling, NFkB, Jak/STAT signaling and Notch pathway.


Keywords: signal transduction, tumor microenvironment, signaling pathways, cancer


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Cancer Development is a multistep process, involving cellular mutation, with selectivity for cells with a high proliferative capacity, survival, invasion and metastasis. The signal transduction pathways that regulate normal cell growth are usually disrupted and abnormal in cancer cells. The mechanisms of these dysregulated signaling pathways provide unique characteristic properties and descriptions of the malignancy at the molecular and cellular level. The loss of growth control observed in the cancer cells is the result of the accumulation of multiple, disordered steps in the regulated signaling cascade. Understanding the regulatory mechanisms and the specific connections in the various signal transduction pathways during cancer progression will help researchers to design futuristic and targeted therapies. Additionally, complex interconnections between signaling pathways may hold the key for a long term cancer cure.

The aim of this Research Topic is to further the understanding of basic cancer biology with regards to signaling pathways and an associated focus on therapeutics and clinical discoveries. Efforts should also be focused on developing understanding around the mechanism of action of therapeutic drugs. Tamoxifen and platinum, for example, are used extensively in treating certain types of tumors but are still poorly understood in terms of the signaling pathways which they target. Equally, the tumor microenvironment, metabolic content and signaling pathways could hold solutions to explaining the positive and negative responses to cancer therapies. Additional investigation into multi-dimensional strategies encompassing signaling molecules, RNAi, antibodies and small molecule inhibitors could provide the necessary specificity to distinguish cancer cells from their normal counterparts, which could provide an opportunity to explore future therapies which correct these distorted pathways.

In our Research Topic, articles that focus on but are not limited to the following topics are welcomed:

- The process by which normal cells are transformed into malignant cells through the changes in the microenvironment.
- Processes that modify the cellular activities and gene expression of an amplified cellular response, with priming of receptor ligand activity and cascading events of the intracellular biochemical pathways.
- Activation of kinases which alter post-translational modifications of key proteins, and investigation of the functional implications of such changes.
- The role of non-enzymatic secondary messengers, including lipids, adaptor proteins and ion binding proteins.
- Signaling pathways downstream of RTKs targeted by the PI3K-Akt pathway, the Ras GTPase, Raf-MEK-ERK MAP kinase, GAP-Rheb GTPase , Wnt signaling, NFkB, Jak/STAT signaling and Notch pathway.


Keywords: signal transduction, tumor microenvironment, signaling pathways, cancer


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

15 October 2021 Abstract
31 January 2022 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

15 October 2021 Abstract
31 January 2022 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..